Dr. Lauriello is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
833 Chestnut St
Ste 210
Philadelphia, PA 19107Phone+1 215-955-6913
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1986 - 1990
- Lewis Katz School of Medicine at Temple UniversityClass of 1986
Certifications & Licensure
- CA State Medical License 1990 - 2025
- PA State Medical License 2019 - 2024
- MO State Medical License 2009 - 2020
- NM State Medical License 1994 - 2010
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
Clinical Trials
- Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 501 citationsThe ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic dataPaul M. Thompson, Jason L. Stein, Sarah E. Medland, Derrek P. Hibar, Alejandro Arias Vasquez
Brain Imaging and Behavior. 2014-06-01 - 81 citationsTuning in to the Voices: A Multisite fMRI Study of Auditory HallucinationsJudith M. Ford, Brian J. Roach, Kasper W. Jorgensen, Jessica A. Turner, Gregory G. Brown
Schizophrenia Bulletin. 2009-01-01 - 192 citationsDysregulation of working memory and default‐mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC studyDae Il Kim, Dara S. Manoach, Daniel H. Mathalon, Jessica A. Turner, Maggie V. Mannell
Human Brain Mapping. 2009-11-01
Other
- Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugsLauriello J, Campbell AR
http://www.uptodate.com/contents/pharmacotherapy-for-schizophrenia-long-acting-injectable-antipsycho
UpToDate, Wolters Kluwer Health - 2013-02-14
Press Mentions
- How to Recognize Tardive DyskinesiaOctober 3rd, 2024
- Assessing Tardive Dyskinesia RiskSeptember 5th, 2024
- Aripiprazole Lauroxil Appears to Improve Schizophrenia Symptoms Safely, SignificantlyAugust 26th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: